Labeler
Zydus Pharmaceuticals USA Inc. NDC Codes
Zydus Pharmaceuticals USA Inc. lists 626 finished drug products in the FDA NDC Directory under NDC labeler codes 68382, 70710.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Isotretinoin, Riociguat, brivaracetam, dasatinib, tofacitinib, Eltrombopag, Beizray, Carbidopa and Levodopa, Jaythari, Deflazacort, gadobutrol, Verapamil hydrochloride, Diazepam, gabapentin, oxcarbazepine
- Active ingredients
- Deflazacort, Isotretinoin, Riociguat, Brivaracetam, Dasatinib, Tofacitinib citrate, Eltrombopag olamine, Carbidopa, Levodopa, Gadobutrol, Verapamil hydrochloride, Diazepam
- NDC labeler codes
- 68382, 70710
- Strengths (from the 100 most recently listed products)
- Gadobutrol 604.72 mg/mL; Docetaxel anhydrous 20 mg/mL; Deflazacort 22.75 mg/mL; Deflazacort 18 mg/1; Deflazacort 30 mg/1; Deflazacort 36 mg/1; Deflazacort 6 mg/1; Riociguat .5 mg/1; Riociguat 1 mg/1; Riociguat 1.5 mg/1; Riociguat 2 mg/1; Riociguat 2.5 mg/1; Fluvoxamine maleate 100 mg/1; Fluvoxamine maleate 150 mg/1; Sugammadex sodium 200 mg/2mL; Sugammadex sodium 500 mg/5mL; Ranibizumab .3 mg/.05mL; Ranibizumab .5 mg/.05mL; Tofacitinib citrate 10 mg/1; Fluorescein sodium 100 mg/mL
- Dosage forms
- Tablet, Tablet, Film coated, Injection, Solution, Capsule, Injection, Capsule, Extended release, Kit, Gel, Tablet, Extended release, Tablet, Film coated, Extended release, Suspension, Liquid, Tablet, For suspension, Powder, For solution
- Routes
- Oral, Intravenous, Intramuscular, Subcutaneous, Rectal, Intravitreal
- Drug classes (FDA established)
- Corticosteroid, Serotonin Reuptake Inhibitor, Retinoid, Soluble Guanylate Cyclase Stimulator, Kinase Inhibitor, Janus Kinase Inhibitor, Thrombopoietin Receptor Agonist, Aromatic Amino Acid, Anti-epileptic Agent, Gadolinium-based Contrast Agent, Calcium Channel Blocker, Benzodiazepine, Angiotensin 2 Receptor Blocker, Neprilysin Inhibitor, Tetracycline-class Drug, Vascular Endothelial Growth Factor Inhibitor, Diagnostic Dye, Nitrogen Binding Agent, Sodium-Glucose Cotransporter 2 Inhibitor, Endothelin Receptor Antagonist, Microtubule Inhibitor, CCR5 Co-receptor Antagonist, Calcitonin, Oxidation-Reduction Agent, Phosphate Binder, Xanthine Oxidase Inhibitor, Arteriolar Vasodilator, Enzyme Stabilizer, Glucosylceramide Synthase Inhibitor
- HCPCS / J-code
- J2778 — Injection, ranibizumab, 0.1 mg
- Package NDCs
- 166 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Colestipol hydrochloride | Colestipol hydrochloride 1 g/1 | Tablet, Film coatedOral | 70710-1467 | 70710-1467-0570710-1467-07 | — |
| Bortezomib | Bortezomib 1 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous, Subcutaneous | 70710-1411 | 70710-1411-01 | — |
| Nortriptyline Hydrochloride | Nortriptyline hydrochloride 25 mg/1 | CapsuleOral | 70710-1154 | 70710-1154-0170710-1154-0370710-1154-05 | — |
| Nortriptyline Hydrochloride | Nortriptyline hydrochloride 10 mg/1 | CapsuleOral | 70710-1153 | 70710-1153-0170710-1153-0370710-1153-05 | — |
| Nortriptyline Hydrochloride | Nortriptyline hydrochloride 50 mg/1 | CapsuleOral | 70710-1155 | 70710-1155-0170710-1155-0370710-1155-05 | — |
| Nortriptyline Hydrochloride | Nortriptyline hydrochloride 75 mg/1 | CapsuleOral | 70710-1156 | 70710-1156-0170710-1156-0370710-1156-05 | — |
| Potassium Chloride | Potassium chloride 1500 mg/1 | Tablet, Extended releaseOral | 68382-740 | 68382-0740-0168382-0740-0568382-0740-10 | — |
| Potassium Chloride | Potassium chloride 750 mg/1 | Tablet, Extended releaseOral | 68382-861 | 68382-0861-0168382-0861-10 | — |
| Propafenone Hydrochloride | Propafenone hydrochloride 425 mg/1 | Capsule, Extended releaseOral | 68382-524 | 68382-0524-0568382-0524-14 | — |
| Propafenone Hydrochloride | Propafenone hydrochloride 225 mg/1 | Capsule, Extended releaseOral | 68382-522 | 68382-0522-0568382-0522-14 | — |
| Propafenone Hydrochloride | Propafenone hydrochloride 325 mg/1 | Capsule, Extended releaseOral | 68382-523 | 68382-0523-0568382-0523-14 | — |
| vigabatrin | Vigabatrin 500 mg/1 | Tablet, Film coatedOral | 70710-1287 | 70710-1287-01 | — |
| Fulvestrant | Fulvestrant 50 mg/mL | Injection, SolutionIntramuscular | 70710-1688 | 70710-1688-08 | — |
| Nelarabine | Nelarabine 5 mg/mL | InjectionIntravenous | 70710-1726 | 70710-1726-0170710-1726-08 | — |
| Nystatin | Nystatin 100000 [USP'U]/g | PowderTopical | 68382-370 | 68382-0370-0168382-0370-0268382-0370-03 | — |
| Mesalamine | Mesalamine .375 g/1 | Capsule, Extended releaseOral | 68382-452 | 68382-0452-19 | — |
| Emtricitabine and tenofovir disoproxil fumarate | Emtricitabine 167 mg/1; Tenofovir disoproxil fumarate 250 mg/1 | Tablet, Film coatedOral | 70710-1366 | 70710-1366-0370710-1366-0470710-1366-09 | — |
| Emtricitabine and tenofovir disoproxil fumarate | Emtricitabine 100 mg/1; Tenofovir disoproxil fumarate 150 mg/1 | Tablet, Film coatedOral | 70710-1364 | 70710-1364-0370710-1364-0470710-1364-09 | — |
| Emtricitabine and tenofovir disoproxil fumarate | Emtricitabine 133 mg/1; Tenofovir disoproxil fumarate 200 mg/1 | Tablet, Film coatedOral | 70710-1365 | 70710-1365-0370710-1365-0470710-1365-09 | — |
| Fluphenazine Hydrochloride | Fluphenazine hydrochloride 5 mg/1 | Tablet, Film coatedOral | 70710-1490 | 70710-1490-0170710-1490-05 | — |
| Fluphenazine Hydrochloride | Fluphenazine hydrochloride 10 mg/1 | Tablet, Film coatedOral | 70710-1491 | 70710-1491-0170710-1491-05 | — |
| Fluphenazine Hydrochloride | Fluphenazine hydrochloride 2.5 mg/1 | Tablet, Film coatedOral | 70710-1489 | 70710-1489-0170710-1489-05 | — |
| Fluphenazine Hydrochloride | Fluphenazine hydrochloride 1 mg/1 | Tablet, Film coatedOral | 70710-1488 | 70710-1488-0170710-1488-05 | — |
| Colchicine | Colchiceine .3 mg/1 | TabletOral | 70710-1571 | 70710-1571-0170710-1571-0370710-1571-05+1 more | — |
| Famotidine | Famotidine 40 mg/5mL | Powder, For suspensionOral | 68382-444 | 68382-0444-05 | — |
| Enoxaparin Sodium | Enoxaparin sodium 60 mg/.6mL | Injection, SolutionIntravenous, Subcutaneous | 70710-1759 | 70710-1759-06 | — |
| Enoxaparin Sodium | Enoxaparin sodium 30 mg/.3mL | Injection, SolutionIntravenous, Subcutaneous | 70710-1757 | 70710-1757-06 | — |
| Enoxaparin Sodium | Enoxaparin sodium 40 mg/.4mL | Injection, SolutionIntravenous, Subcutaneous | 70710-1758 | 70710-1758-06 | — |
| Enoxaparin Sodium | Enoxaparin sodium 150 mg/mL | Injection, SolutionIntravenous, Subcutaneous | 70710-1763 | 70710-1763-06 | — |
| Enoxaparin Sodium | Enoxaparin sodium 80 mg/.8mL | Injection, SolutionIntravenous, Subcutaneous | 70710-1760 | 70710-1760-06 | — |
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | Injection, SolutionIntravenous, Subcutaneous | 70710-1761 | 70710-1761-06 | — |
| Enoxaparin Sodium | Enoxaparin sodium 120 mg/.8mL | Injection, SolutionIntravenous, Subcutaneous | 70710-1762 | 70710-1762-06 | — |
| Emtricitabine and tenofovir disoproxil fumarate | Emtricitabine 200 mg/1; Tenofovir disoproxil fumarate 300 mg/1 | Tablet, Film coatedOral | 70710-1367 | 70710-1367-0370710-1367-0470710-1367-09 | — |
| Fomepizole | Fomepizole 1 g/mL | Injection, SolutionIntravenous | 70710-1478 | 70710-1478-01 | — |
| Droxidopa | Droxidopa 300 mg/1 | CapsuleOral | 70710-1391 | 70710-1391-09 | — |
| Droxidopa | Droxidopa 100 mg/1 | CapsuleOral | 70710-1389 | 70710-1389-09 | — |
| Droxidopa | Droxidopa 200 mg/1 | CapsuleOral | 70710-1390 | 70710-1390-09 | — |
| Sodium Phenylacetate And Sodium Benzoate | Sodium phenylacetate 100 mg/mL; Sodium benzoate 100 mg/mL | Injection, Solution, ConcentrateIntravenous | 68382-396 | 68382-0396-01 | — |
| Liothyronine sodium | Liothyronine sodium 5 ug/1 | TabletOral | 68382-582 | 68382-0582-0168382-0582-10 | — |
| Liothyronine sodium | Liothyronine sodium 25 ug/1 | TabletOral | 68382-583 | 68382-0583-0168382-0583-10 | — |
| Liothyronine sodium | Liothyronine sodium 50 ug/1 | TabletOral | 68382-584 | 68382-0584-0168382-0584-10 | — |
| Ursodiol | Ursodiol 300 mg/1 | CapsuleOral | 70710-1483 | 70710-1483-01 | — |
| Benztropine Mesylate | Benztropine mesylate 1 mg/mL | InjectionIntramuscular, Intravenous | 68382-860 | 68382-0860-10 | — |
| carmustine | — | Kit | 70710-1525 | 70710-1525-09 | — |
| Meclizine Hydrochloride | Meclizine hydrochloride 12.5 mg/1 | TabletOral | 70710-1161 | 70710-1161-0070710-1161-0170710-1161-03+2 more | — |
| Meclizine Hydrochloride | Meclizine hydrochloride 25 mg/1 | TabletOral | 70710-1162 | 70710-1162-0070710-1162-0170710-1162-03+2 more | — |
| Albuterol | Albuterol sulfate 2 mg/1 | TabletOral | 70710-1061 | 70710-1061-01 | — |
| Albuterol | Albuterol sulfate 4 mg/1 | TabletOral | 70710-1062 | 70710-1062-0170710-1062-05 | — |
| Verapamil Hydrochloride | Verapamil hydrochloride 2.5 mg/mL | Injection, SolutionIntravenous | 70710-1643 | 70710-1643-07 | — |
| Verapamil Hydrochloride | Verapamil hydrochloride 2.5 mg/mL | Injection, SolutionIntravenous | 70710-1644 | 70710-1644-05 | — |
Zydus Pharmaceuticals USA Inc.: common questions
- What is Zydus Pharmaceuticals USA Inc.'s NDC labeler code?
- 68382, 70710. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Zydus Pharmaceuticals USA Inc.?
- Med-Code's HCPCS directory matches J2778 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.